PDS Biotechnology Corp (PDSB) — Cash Flow-to-Debt Ratio
PDS Biotechnology Corp (PDSB) has a Cash Flow-to-Debt Ratio of -0.17x as of December 2025, meaning its operating cash flow of $-3.70 Million could theoretically repay 0% of its total liabilities ($21.24 Million) in one year. See PDSB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PDS Biotechnology Corp Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for PDS Biotechnology Corp across 14 annual periods. Also explore PDSB net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PDS Biotechnology Corp (2012–2025)
Year-by-year debt coverage analysis for PDS Biotechnology Corp. For market capitalisation and broader financial context, see PDSB market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1306.45x | $-27.75 Billion | $21.24 Million | ▼ -98186.6% |
| 2024 | -1.33x | $-35.03 Million | $26.35 Million | ▼ -31.4% |
| 2023 | -1.01x | $-33.64 Million | $33.26 Million | ▼ -29.8% |
| 2022 | -0.78x | $-25.71 Million | $33.01 Million | ▲ +75.1% |
| 2021 | -3.13x | $-12.49 Million | $3.99 Million | ▲ +10.4% |
| 2020 | -3.50x | $-13.15 Million | $3.76 Million | ▲ +46.0% |
| 2019 | -6.47x | $-18.07 Million | $2.79 Million | ▼ -24.5% |
| 2018 | -5.19x | $-33.15 Million | $6.38 Million | ▼ -286.1% |
| 2017 | -1.35x | $-40.70 Million | $30.25 Million | ▲ +9.6% |
| 2016 | -1.49x | $-32.19 Million | $21.64 Million | ▲ +20.6% |
| 2015 | -1.87x | $-21.75 Million | $11.62 Million | ▼ -765.2% |
| 2014 | -0.22x | $-9.71 Million | $44.88 Million | ▲ +35.2% |
| 2013 | -0.33x | $-8.04 Million | $24.08 Million | ▲ +47.2% |
| 2012 | -0.63x | $-2.25 Million | $3.55 Million | — |